Early-Stage Breast Carcinoma
Information
- Disease name
- Early-Stage Breast Carcinoma
- Disease ID
- Description
Disease area statistics
[No Data.]
Chromosome band
[No Data.]
Annotation
| Genes | Mutation | Description | Source | Links |
|---|
| NCT ID | Status | Phase | Summary | Start date | Completion date |
|---|---|---|---|---|---|
| NCT02568839 | Active, not recruiting | Phase 2/Phase 3 | Neoadjuvant Response-guided Treatment of HER2 Positive Breast Cancer | November 2014 | February 2029 |
| NCT02592083 | Active, not recruiting | Phase 2 | Neoadjuvant Response-guided Treatment of Slowly Proliferating Hormone Receptor Positive Tumors | October 2015 | February 2029 |
| NCT02603679 | Active, not recruiting | Phase 2 | Neoadjuvant Response-guided Treatment of Luminal B-type Tumors and Luminal A-type Tumors With Node Metastases | February 2015 | December 31, 2031 |
| NCT02474641 | Active, not recruiting | N/A | Hypofractionation With Simultaneous Integrated Boost vs. Standard Fractionation in Early Breast Cancer | June 16, 2015 | March 31, 2028 |
| NCT03025139 | Active, not recruiting | N/A | Mindfulness Meditation or Survivorship Education in Improving Behavioral Symptoms in Younger Stage 0-III Breast Cancer Survivors (Pathways to Wellness) | February 20, 2017 | February 1, 2024 |
| NCT03077841 | Active, not recruiting | Phase 2/Phase 3 | Hypofractionated Partial Breast Irradiation in Treating Patients With Early Stage Breast Cancer | March 6, 2017 | August 31, 2024 |
| NCT02129686 | Completed | N/A | A Pilot Study of Acupuncture for Chemotherapy-induced Peripheral Neuropathy in Breast Cancer Patients | June 1, 2014 | June 1, 2021 |
| NCT02310984 | Completed | PICTURE Breast XS: Patient Information Combined for Local Therapy oUtcome Assessment in bREast Cancer - Cross-sectional | March 2014 | December 2016 | |
| NCT02441946 | Completed | Phase 2 | A Neoadjuvant Study of Abemaciclib (LY2835219) in Postmenopausal Women With Hormone Receptor Positive, HER2 Negative Breast Cancer | August 2015 | February 12, 2018 |
| NCT02481128 | Completed | N/A | Surgical Trial to Evaluate the Impact of a Lymphoscintigraphy Prior to Sentinel Node Biopsy in Early Breast Cancer | May 2014 | January 2017 |
| NCT02806817 | Completed | Early Phase 1 | ME-344 in Early HER2-negative Breast Cancer With Antiangiogenic-induced Mitochondrial Metabolism | July 2016 | November 2018 |
| NCT04081389 | Completed | Phase 1 | Chemokine Modulation Therapy and Standard Chemotherapy Before Surgery for the Treatment of Early Stage Triple Negative Breast Cancer | December 6, 2019 | February 27, 2023 |
| NCT04294225 | Completed | Phase 2 | Anastrozole and Letrozole After Surgery for the Treatment of Stage I-III Breast Cancer | April 28, 2020 | December 12, 2022 |
| NCT04290897 | Recruiting | Phase 2 | Oxaloacetate for the Improvement of Cognitive Complaints in Stage 0-IIIA Breast Cancer Survivors | September 29, 2021 | November 1, 2025 |
| NCT02947425 | Unknown status | TARGeted Intraoperative radioTherapy (TARGIT) Registry Database | July 2013 | July 2022 | |
| NCT02511301 | Unknown status | Phase 1/Phase 2 | Circadian Thermal Sensing to Detect Breast Disease | June 2015 | February 2020 |
| NCT04560439 | Withdrawn | N/A | Diabetes Prevention Program (METFIT) in Reducing Insulin Resistance in Stage I-III Breast Cancer Survivors | June 15, 2022 | June 15, 2023 |